Disease Outcomes With Ublituximab in Treatment-Naive Participants: Subpopulation Analyses of the Phase 3 ULTIMATE I and II Studies in Participants With Relapsing Multiple Sclerosis

Drug Category : Array
Conference Category : Array
Lead Author : Steinman L, et al.
Published Date : 26/10/2022
Download Link : https://www.tgtherapeutics.com/wp-content/uploads/2022/10/1055-TGXT-ECTRIMS-2022-Tx-Naive-13Oct22a.pdf
Download Text : Download
Popup Confirmation? :
site-sidebar-layout : default
ast-site-content-layout : default
site-content-style : default
site-sidebar-style : default
theme-transparent-header-meta : default
stick-header-meta : default
astra-migrate-meta-layouts : set
Scroll to Top